The prescribing pattern of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists in patient with type two diabetes mellitus: A two-center retrospective cross-sectional study

• Main Authors: Ghazwa B. Korayem (Author), Omar A. Alshaya (Author), Albandari A. Alghamdi (Author), Shahad S. Alanazi (Author), Renad T. Almutib (Author), Mahdi Alsaileek (Author), Abdulrahman Alrashidi (Author), Nasser Aldosari (Author), Nader Bin Sheraim (Author), Majed S. Al Yami (Author), Omar A. Almohammed (Author)
• Format: Book
• Published: Frontiers Media S.A., 2022-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

BackgroundThe use of sodium-glucose cotransporter-2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1 RA) in patients with type 2 diabetes mellitus (T2DM) remains limited, especially in those with other compelling indications. Thus, this study aimed to describe the prescribing...